immunosuppressants
Immunosuppressants are used to treat very severe eczema and usually when all other conventional treatments have failed: a last resort.
Immunosuppressants are potent systemic drugs used to slow down the whole body’s immune system which causes inflammation in the skin. These drugs are usually only administered for a limited period of time; however they may be used for longer periods of time than that of oral steroids.
Most eczema sufferers have periods when their symptoms are exacerbated and often their usual medications don’t work. At these times immunosuppressants may be recommended.
Immunosuppressants are administered under medical supervision by a specialist either through an injection or in a tablet form.
 |
Topical immunosuppressant methods may also be used. Topical immunosuppressants come in ointment or cream form and are applied directly to the skin. They reduce inflammation of the skin associated with flare-ups. Topical immunosuppressants work differently to cortisone creams and have not been associated with the thinning of the skin like steroids. They are usually prescribed if topical steroid treatments haven’t worked. |
Immunosuppressant medicines can increase your susceptibility to infections because your suppressed immune system is less able, than normal, to fight off bacteria, viruses and other foreign substances.
Many medicines can interact with immunosuppressants so it is very important that you let your doctor know what medicines you are already taking or using, including prescription medicines, those bought without a prescription and herbal medicines before undertaking immunosuppressant treatment. Patients should also avoid foods that react with immunosuppressant such as grapefruit, high potassium foods such as dried fruits, tomatoes and bananas – but your doctor or specialist will be able to give you more information about this.
If it is necessary for you to use immunosuppressants, regular check-ups to monitor your treatment will be required.
Information written by the talkhealth panel
Last Reviewed: 24 January 2011
Next Review Date: 24 January 2013
